Phibro Animal Health (NASDAQ:PAHC) Stock Price Up 6.8% on Analyst Upgrade

Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) rose 6.8% during mid-day trading on Monday after Barclays raised their price target on the stock from $20.00 to $22.00. Barclays currently has an underweight rating on the stock. Phibro Animal Health traded as high as $24.21 and last traded at $25.30. Approximately 92,480 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 154,656 shares. The stock had previously closed at $23.69.

A number of other brokerages have also issued reports on PAHC. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research report on Tuesday, December 17th. StockNews.com downgraded shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, February 6th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Phibro Animal Health has a consensus rating of "Hold" and an average price target of $21.00.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Truist Financial Corp purchased a new position in Phibro Animal Health in the 2nd quarter valued at $308,000. Sanctuary Advisors LLC purchased a new stake in shares of Phibro Animal Health in the second quarter valued at about $481,000. SG Americas Securities LLC purchased a new stake in shares of Phibro Animal Health in the third quarter valued at about $276,000. CWM LLC increased its stake in shares of Phibro Animal Health by 190.8% during the third quarter. CWM LLC now owns 6,363 shares of the company's stock worth $143,000 after acquiring an additional 4,175 shares during the period. Finally, nVerses Capital LLC purchased a new position in Phibro Animal Health during the third quarter worth about $70,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Stock Performance

The stock's 50-day moving average is $22.03 and its 200 day moving average is $21.82. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of 52.98, a P/E/G ratio of 0.53 and a beta of 0.52. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.69.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, analysts predict that Phibro Animal Health Co. will post 1.94 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be issued a $0.12 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.90%. Phibro Animal Health's dividend payout ratio is presently 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.